Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancer|November 2, 2022
Modeling the impact of novel systemic treatments on lung cancer screening benefitsKemal Caglar Gogebakan, Jane Lange, Christopher G Slatore, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2024
Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease ModelingJane M Lange, Kemal Caglar Gogebakan, Roman Gulati, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 2023
Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?Lukas Owens, Kemal Caglar Gogebakan, Usha Menon, et al.Cancer|April 27, 2021
Impact of novel systemic therapies on the first-year costs of care for melanoma among Medicare beneficiariesKemal Caglar Gogebakan, Kumar Mukherjee, Elizabeth G Berry, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2020
Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based ApproachKemal Caglar Gogebakan, Elizabeth G Berry, Alan C Geller, et al.JAMA Network Open|October 9, 2025
Clinical Significance of a Multicancer Screening Trial With Stage-Based End PointsKemal Caglar Gogebakan, Jane Lange, Lukas Owens, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2025
Estimating the Opportunity for Early Detection of Ovarian Cancer Using Individual-Patient Data from a Large Randomized Controlled TrialMarc D Ryser, Shannon T Holloway, Raphaël Morsomme, et al.Cancer|October 18, 2025
Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survivalKemal Caglar Gogebakan, Zizi Elsisi, Felipe Montano-Campos, et al.Pageof 1